This is an over the counter product - it does not require prescription.
Ships on ICE, Please choose 2nd day Shipping for this item. For Canada customers, please choose Worldwide Saver as the shipping method.
This item ships with ice pack, please choose 2nd Day
or Next Day Air as shipping method to avoid delay in processing.
Canine Bordetella Bronchiseptica, Adenovirus Type 2, Parainfluenza Modified
Live vaccine. Intranasal vaccine for healthy dogs as young as 3 weeks of age.
Vaccinate at least 1 week prior to possible exposure. Apply nasal applicator
to syringe (syringe not included). Can use 0.5ml to 1ml to rehydrate vaccine
depending on comfort level of the dog. Revaccinate annually.
Canine Parainfluenza-Bordetella bronchiseptica Vaccine, Modified Live Virus,
Avirulent Live Culture
Contents: Canine parainfluenza, modified live virus and Bordetella bronchiseptica,
avirulent live culture.
This vaccine contains penicillin, streptomycin and nystatin as preservatives.
Indications: INTRA-TRAC®-II is recommended for use as an aid in
the control and prevention of disease associated with canine parainfluenza and
Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older.
These agents have been implicated as playing a role in the etiology of the condition
known as canine cough.
Dosage and Administration:
Preparation of the Vaccine:
1. Rehydrate the vaccine with the accompanying sterile diluent.
2. Draw the vaccine back into the syringe.
3. Remove needle from syringe.
4. Apply nasal applicator tip to syringe.
How to Vaccinate: Instill the rehydrated vaccine into one or both nostrils
of dogs as illustrated below.
When to Vaccinate: Vaccinate dogs at 3 weeks of age or older. Revaccinate
Precaution(s): Store at 2° to 7°C (35° to 45°F). Use
entire contents when first opened. Burn containers and all unused contents.
This product is designed for intranasal use only with the enclosed applicators.
Systemic reactions resulting from inadvertent intramuscular or subcutaneous
injection have been reported. Symptoms may include vomiting, diarrhea, lethargy,
inappetence, jaundice, and death associated with liver failure. Localized tissue
necrosis at the injection site has also been reported. If inadvertent injection
occurs, monitor the dog closely. Supportive therapy including IV fluids and
treatment with gentamicin, tetracycline or trimethoprim/sulfa may be indicated.
Post vaccinal reactions consisting of mild canine cough syndrome may occur
following use of this vaccine.
If anaphylactoid reaction occurs, use epinephrine.
Warning(s): For intranasal use only. For veterinary use only.
Presentation: 25 x 1 mL single dose vials, 150 x 1 mL single dose vials,
and 2 x 5 mL multiple dose vials, with sterile diluent and nasal applicators.